Select for export A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674221083868 PubMed 35285280 Copy citation Copy BibTeX Unknown journal 2022-03-11 Kisely S, Connor M, Somogyi AA, Siskind D. Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11864-022-00954-4 PubMed 35254595 Copy citation Copy BibTeX Unknown journal 2022-03-06 Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF. Europe PMC Published psilocybin DepressionAddictionEnd-of-Life Distress Other More
Select for export Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06083-y PubMed 35253070 Copy citation Copy BibTeX Unknown journal 2022-03-06 Sarparast A, Thomas K, Malcolm B, Stauffer CS. Europe PMC Published psilocybin DepressionPTSDPharmacology Randomized Controlled Trial More
Select for export The therapeutic potential of psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2047929 PubMed 35225143 Copy citation Copy BibTeX Unknown journal 2022-03-01 van Amsterdam J, van den Brink W. Europe PMC Published psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06020-5 PubMed 35234983 Copy citation Copy BibTeX Psychopharmacology 2022-03-01 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N Europe PMC Published psilocybinpsilocin DepressionReceptor Pharmacology Other More
Select for export The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073758 PubMed 35253518 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-02-28 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. Europe PMC Published psilocybin Mechanism of ActionPsychological FlexibilityObservational Study Observational Study More
Select for export The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2044096 PubMed 35225726 Copy citation Copy BibTeX Unknown journal 2022-02-27 Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-022-01846-9 PubMed 35197453 Copy citation Copy BibTeX Translational Psychiatry 2022-02-22 Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM Europe PMC Published psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Animal Study More
Select for export Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-06580-2 PubMed 35173246 Copy citation Copy BibTeX Scientific Reports 2022-02-15 Jones GM, Nock MK. Europe PMC Published psilocybin AddictionPersonality ChangeObservational Study Observational Study More
Select for export The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpainsymman.2022.01.024 PubMed 35157985 Copy citation Copy BibTeX Unknown journal 2022-02-10 Maia LO, Beaussant Y, Garcia ACM. Europe PMC Published psilocybin AnxietySpiritualityRandomized Controlled Trial Randomized Controlled Trial More
Select for export Hallucinogen Use and Misuse in Older Adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.cger.2021.07.007 PubMed 34794703 Copy citation Copy BibTeX Unknown journal 2022-01-31 Redden WM, Paracha SU, Sheheryar Q. Europe PMC Published psilocybin AgingOlder Adults Other More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export [Are psychedelics fast acting antidepressant agents?] Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00115-021-01255-1 PubMed 35103814 Copy citation Copy BibTeX Unknown journal 2022-01-31 Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M Europe PMC Published psilocybin Depression Other More
Select for export Structure-based discovery of nonhallucinogenic psychedelic analogs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1126/science.abl8615 PubMed 35084960 Copy citation Copy BibTeX Science 2022-01-26 Cao D, Yu J, Wang H, Luo Z, Liu X, He L Europe PMC Published psilocybinpsilocin DepressionReceptor PharmacologyAnimal Study Animal Study More
Select for export Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. No abstract availability was recorded for this entry. Details DOI 10.1080/02791072.2021.1983673 PubMed 35083957 Copy citation Copy BibTeX Unknown journal 2022-01-26 Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. Europe PMC Published psilocybin OCDReview Article Review Article More
Select for export Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06066-z PubMed 35076721 Copy citation Copy BibTeX Psychopharmacology 2022-01-24 Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y Europe PMC Published psilocybin Clinical TrialHealthy Volunteers Clinical Trial More
Select for export Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11019-022-10070-7 PubMed 35064398 Copy citation Copy BibTeX Unknown journal 2022-01-21 Miceli McMillan R, Jordens C. Europe PMC Published psilocybin Depression Other More
Select for export Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1714-9097 PubMed 35045580 Copy citation Copy BibTeX Unknown journal 2022-01-18 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Systematic Review More
Select for export [Psilocybin compared with escitalopram for depression]. Abstract available at the source but not redistributed here. Read at source. Details PubMed 35138714 Copy citation Copy BibTeX PubMed 2022-01-16 Strous JFM. Europe PMC Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
